<DOC>
	<DOCNO>NCT01835782</DOCNO>
	<brief_summary>The purpose study determine safety L-Serine subject Amyotrophic Lateral Sclerosis ( ALS ) vary dos .</brief_summary>
	<brief_title>Determining Safety L-serine ALS</brief_title>
	<detailed_description>Previous study Guamian ALS-Parkinson 's Dementia complex identify Î²-methylamino-L-alanine ( BMAA ) , potential neurotoxin responsible disease . BMAA non-essential amino acid produce cyanobacterium present ecosystem . Subsequently several group identify high concentration BMAA brain tissue patient North America Europe several neurodegenerative disease include ALS , Parkinson 's Disease Alzheimer 's Diseases . It hypothesize chronic intake BMAA diet lead mis-incorporation amino acid brain protein , produce slow neuronal damage recent evidence show BMAA mis-incorporated protein neuronal cell line via seryl tRNA synthetase , thereby produce protein mis-folding protein aggregate , lead cell death . It demonstrate mammalian neuronal cell culture exogenous L-serine could prevent BMAA neurotoxin mis-incorporated protein , thereby prevent cell death high dos L-serine may compete transport number non-essential amino acid across blood-brain barrier via y+ transporter . These finding lead u believe high dos L-serine could possibly stop mis-incorporation BMAA brain protein turn would slow even abate progression ALS . This study determine safety different dose L-serine give ALS subject 0.5 gm twice daily ( BID ) , 2.5gm BID , 7.5g BID 15 gram BID six month .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>1 . Age 1885 2 . Male Female 3 . Clinically diagnose probable definite ALS base El Escorial criterion 4 . ALSFRSR &gt; 25 5 . Able provide inform consent comply medical procedure 1 . Outside age range 1885 2 . Subjects force vital capacity ( FVC ) 60 % 3 . Evidence motor neuron disease 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>ALS</keyword>
	<keyword>L-Serine</keyword>
	<keyword>BMAA</keyword>
</DOC>